Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Today's Market: Other Potential Buyout Targets For Pfizer
Seeking Alpha
Monday, April 21, 2014 - 11:25am
tags:
M&A, Pfizer, AstraZeneca, Celgene, Biogen Idec, Amgen
Arena Pharmaceuticals' Belviq Sales Dip - Why?
Seeking Alpha
Monday, April 21, 2014 - 11:21am
tags:
Arena Pharmaceuticals, Belviq
Sarepta Surges on Optimism Over Muscular Dystrophy Drug
Bloomberg
Monday, April 21, 2014 - 10:32am
tags:
Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen
Aastrom announces definitive agreement to acquire Sanofi's CTRM business
The Fly on the Wall
Monday, April 21, 2014 - 10:30am
tags:
Aastrom Biosciences, M&A, Sanofi, CTRM, cell therapy
Potential Impact On R&D Of A Pfizer Takeover Of AstraZeneca
Forbes
Monday, April 21, 2014 - 10:26am
tags:
R&D, Pfizer, AstraZeneca, M&A
Analysts differ on chances of Pfizer interest in AstraZeneca
The Fly on the Wall
Monday, April 21, 2014 - 10:23am
tags:
Pfizer, M&A, AstraZeneca
Will Edwards Snatch Defeat From The Jaws Of Its Victory Over Medtronic?
Forbes
Monday, April 21, 2014 - 10:21am
tags:
Medtronic, Edwards Lifesciences, devices, TAVR, patents
Johnson & Johnson's New Diabetes Drug: A Blockbuster in the Making?
Motley Fool
Monday, April 21, 2014 - 10:17am
tags:
JNJ, diabetes, Invokana
Natco Pharma jumps on U.S. top court stance
Yahoo/Reuters
Monday, April 21, 2014 - 10:02am
tags:
Natco, Supreme Court, generics, Teva Pharmaceuticals, Copaxone, MS
Pfizer Said to Have Held Now-Dormant Talks to Buy AstraZeneca
Yahoo/Bloomberg
Monday, April 21, 2014 - 10:01am
tags:
Pfizer, M&A, AstraZeneca
Verastem: Cancer May Have Met Its Match
Seeking Alpha
Monday, April 21, 2014 - 10:00am
tags:
Verastem, cancer, stem cells
NJ biotech firm develops 'female Viagra' for women with low sexual desire
The Star Ledger, NJ
Sunday, April 20, 2014 - 10:02am
tags:
bremelanotide, Palatin, female sexual dysfunction
Acadia Pharmaceuticals: 4 Different Insiders Have Sold Shares This Month
Seeking Alpha
Sunday, April 20, 2014 - 9:35am
tags:
Acadia
Pfizer mulls $100 billion bid for AstraZeneca: report
Yahoo/Reuters
Sunday, April 20, 2014 - 9:34am
tags:
Pfizer, Astra Zeneca, M&A
China Biotech In Review: Unnamed Entity Raises Chindex Bid To $23
Seeking Alpha
Sunday, April 20, 2014 - 9:31am
tags:
China, Chindex, Changchun BCHT Biotechnology, Techne, Zhejiang Hisun Pharma, JNJ
Why Johnson & Johnson's Patent Expiration Profile Is Fantastic
Seeking Alpha
Sunday, April 20, 2014 - 9:29am
tags:
JNJ, patents
1 of These 3 Cratering Biotechs is a Buy
Motley Fool
Sunday, April 20, 2014 - 9:27am
tags:
Halozyme, Exelixis, Vivus
Flamel Technologies: Great Buying Opportunity Before Earnings Inflection
Seeking Alpha
Saturday, April 19, 2014 - 11:23am
tags:
Flamel
AbbVie urges U.S. court to avoid gay rights issue in HIV drug case
Yahoo/Reuters
Saturday, April 19, 2014 - 10:23am
tags:
AbbVie
Clinical Trial Of Juno Therapeutics Cell Therapy Restarts
Forbes
Saturday, April 19, 2014 - 10:20am
tags:
Juno Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.